Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Subscribe To Our Newsletter & Stay Updated
